Dimasi, Joseph A.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

INNOVATION IN THE PHARMACEUTICAL INDUSTRY: NEW ESTIMATES OF R&D COSTS

DiMasi, Joseph A., Grabowski, Henry G., Hansen, Ronald W.

Journal:

Journal of Health Economics

Year:

2016

Language:

english

File:

PDF, 389 KB

english, 2016

2

The price of innovation: new estimates of drug development costs

Joseph A DiMasi, Ronald W Hansen, Henry G Grabowski

Journal:

Journal of Health Economics

Year:

2003

Language:

english

File:

PDF, 283 KB

english, 2003

3

Stabilization of cysteine-linked antibody drug conjugates with N-aryl maleimides

Christie, R. James, Fleming, Ryan, Bezabeh, Binyam, Woods, Rob, Mao, Shenlan, Harper, Jay, Joseph, Augustine, Wang, Qianli, Xu, Ze-Qi, Wu, Herren, Gao, Changshou, Dimasi, Nazzareno

Journal:

Journal of Controlled Release

Year:

2015

Language:

english

File:

PDF, 1.54 MB

english, 2015

4

R&D Costs, Innovative Output and Firm Size in the Pharmaceutical Industry

Dimasi, Joseph A., Grabowski, Henry G., Vernon, John

Journal:

International Journal of the Economics of Business

Year:

1995

Language:

english

File:

PDF, 951 KB

english, 1995

5

Emerging Role of Pharmacoeconomics in the Research and Development Decision-Making Process

Dimasi, Joseph A., Caglarcan, Erol, Wood-Armany, Maria

Journal:

PharmacoEconomics

Year:

2001

Language:

english

File:

PDF, 178 KB

english, 2001

6

Research and Development Costs for New Drugs by Therapeutic Category

Dr Joseph A. DiMasi,Ronald W. Hansen,Henry C. Grabowski…

Journal:

PharmacoEconomics

Year:

1995

Language:

english

File:

PDF, 5.09 MB

english, 1995

7

New drug development in the United States from 1963 to 1992

DiMasi, Joseph A, Seibring, Mark A, Lasagna, Louis

Journal:

Clinical Pharmacology & Therapeutics

Year:

1994

Language:

english

File:

PDF, 2.01 MB

english, 1994

8

The Cost of Drug Development

DiMasi, Joseph A., Grabowski, Henry G., Hansen, Ronald W.

Journal:

New England Journal of Medicine

Year:

2015

Language:

english

File:

PDF, 304 KB

english, 2015

9

Research and Development Costs of New Drugs

DiMasi, Joseph A.

Journal:

Year:

2020

File:

PDF, 148 KB

2020

10

New Indications for Already-Approved Drugs: An Analysis of Regulatory Review Times

DiMasi, Joseph A., Kaitin, Kenneth I, Fernandez-Carol, Cecilia, Lasagna, Louis

Journal:

Journal of Clinical Pharmacology

Year:

1991

Language:

english

File:

PDF, 956 KB

english, 1991

11

The Financial Benefits of Faster Development Times: Integrated Formulation Development, Real-Time Manufacturing, and Clinical Testing

DiMasi, Joseph A., Wilkinson, Michael

Journal:

Therapeutic Innovation & Regulatory Science

Year:

2020

File:

PDF, 721 KB

2020

12

Extraordinary claims require extraordinary evidence

Joseph A. DiMasi, Ronald W. Hansen, Henry G. Grabowski

Journal:

Journal of Health Economics

Year:

2005

Language:

english

File:

PDF, 87 KB

english, 2005

13

Economic and Policy Issues in the Pharmaceutical Industry || The Cost of Biopharmaceutical R&D: Is Biotech Different?

Joseph A. DiMasi and Henry G. Grabowski

Journal:

Managerial and Decision Economics

Year:

2007

Language:

english

File:

PDF, 2.07 MB

english, 2007

14

New drug development in the United States from 1963 to 1990

DiMasi, Joseph A, Bryant, Natalie R, Lasagna, Louis

Journal:

Clinical Pharmacology & Therapeutics

Year:

1991

Language:

english

File:

PDF, 1.80 MB

english, 1991

15

Landscape of Innovation for Cardiovascular Pharmaceuticals: From Basic Science to New Molecular Entities

Beierlein, Jennifer M., McNamee, Laura M., Walsh, Michael J., Kaitin, Kenneth I., DiMasi, Joseph A., Ledley, Fred D.

Journal:

Clinical Therapeutics

Year:

2017

Language:

english

File:

PDF, 25.10 MB

english, 2017

16

Competetive development in pharmacologic classes: Market entry and the timing of development

DiMasi, Joseph A., Chakravarthy, Ranjana

Journal:

Clinical Pharmacology & Therapeutics

Year:

2016

Language:

english

File:

PDF, 692 KB

english, 2016

17

Returns on Research and Development for 1990s New Drug Introductions

Grabowski, Henry, Vernon, John, DiMasi, Joseph A.

Journal:

PharmacoEconomics

Year:

2002

Language:

english

File:

PDF, 220 KB

english, 2002

18

Assessing the Financial Benefits of Faster Development Times: The Case of Single-source Versus Multi-vendor Outsourced Biopharmaceutical Manufacturing

DiMasi, Joseph A., Smith, Zachary, Getz, Kenneth A.

Journal:

Clinical Therapeutics

Year:

2018

Language:

english

File:

PDF, 361 KB

english, 2018

19

Drug development costs when financial risk is measured using the Fama–French three-factor model

John A. Vernon, Joseph H. Golec, Joseph A. Dimasi

Journal:

Health Economics

Year:

2010

Language:

english

File:

PDF, 69 KB

english, 2010

20

Private Sector Contributions to Pharmaceutical Science: Thirty-Five Summary Case Histories

Zycher, Benjamin, DiMasi, Joseph A, Milne, Christopher-Paul

Journal:

American Journal of Therapeutics

Year:

2010

Language:

english

File:

PDF, 199 KB

english, 2010

21

The economics of follow-on drug research and development: Trends in entry rates and the timing of development — The authors’ reply

Joseph A. DiMasi,Cherie Paquette

Journal:

PharmacoEconomics

Year:

2005

Language:

english

File:

PDF, 107 KB

english, 2005

22

Setting the record straight on setting the record straight: Response to the Light and Warburton rejoinder

Joseph A. DiMasi, Ronald W. Hansen, Henry G. Grabowski

Journal:

Journal of Health Economics

Year:

2005

Language:

english

File:

PDF, 57 KB

english, 2005

23

The cost of biopharmaceutical R&D: is biotech different?

Joseph A. DiMasi, Henry G. Grabowski

Journal:

Managerial and Decision Economics

Year:

2007

Language:

english

File:

PDF, 160 KB

english, 2007

24

Investigating investment in biopharmaceutical R&D

Carter, Percy H., Berndt, Ernst R., DiMasi, Joseph A., Trusheim, Mark

Journal:

Nature Reviews Drug Discovery

Year:

2016

Language:

english

File:

PDF, 220 KB

english, 2016

25

Success rates for new drugs entering clinical testing in the United States

DiMasi, Joseph A.

Journal:

Clinical Pharmacology & Therapeutics

Year:

1995

Language:

english

File:

PDF, 2.00 MB

english, 1995

26

Assessing Pharmaceutical Research and Development Costs

DiMasi, Joseph A.

Journal:

JAMA Internal Medicine

Year:

2018

Language:

english

File:

PDF, 78 KB

english, 2018

27

Development Times and Approval Success Rates for Drugs to Treat Infectious Diseases

DiMasi, Joseph A., Florez, Maria I., Stergiopoulos, Stella, Peña, Yaritza, Smith, Zachary, Wilkinson, Michael, Getz, Kenneth A.

Journal:

Clinical Pharmacology & Therapeutics

Year:

2019

Language:

english

File:

PDF, 364 KB

english, 2019

28

Pharmaceutical R&D Performance by Firm Size

DiMasi, Joseph A.

Journal:

American Journal of Therapeutics

Year:

2014

Language:

english

File:

PDF, 387 KB

english, 2014

29

Analysis of Review Times for Recent 505(b)(2) Applications

Sakai, Sharon, DiMasi, Joseph A., Getz, Kenneth A.

Journal:

Therapeutic Innovation & Regulatory Science

Year:

2017

Language:

english

File:

PDF, 179 KB

english, 2017

30

Assessing the Financial Value of Patient Engagement

Levitan, Bennett, Getz, Kenneth, Eisenstein, Eric L., Goldberg, Michelle, Harker, Matthew, Hesterlee, Sharon, Patrick-Lake, Bray, Roberts, Jamie N., DiMasi, Joseph

Journal:

Therapeutic Innovation & Regulatory Science

Year:

2018

Language:

english

File:

PDF, 253 KB

english, 2018

31

Economic and Policy Issues in the Pharmaceutical Industry || Commentary [on Scherer (2007), Berndt et al (2007), and Reiffen and Ward (2007)]

Joseph A. DiMasi

Journal:

Managerial and Decision Economics

Year:

2007

Language:

english

File:

PDF, 1.35 MB

english, 2007

32

Innovating by Developing New Uses of Already-Approved Drugs: Trends in the Marketing Approval of Supplemental Indications

DiMasi, Joseph A.

Journal:

Clinical Therapeutics

Year:

2013

Language:

english

File:

PDF, 378 KB

english, 2013

33

Recombinant protein and therapeutic monoclonal antibody drug development in the United States from 1980 to 1994

Gosse, Marilyn E., DiMasi, Joseph A., Nelson, Toben F.

Journal:

Clinical Pharmacology & Therapeutics

Year:

1996

Language:

english

File:

PDF, 2.13 MB

english, 1996

34

The Value of Improving the Productivity of the Drug Development Process

DiMasi, Joseph A.

Journal:

PharmacoEconomics

Year:

2002

Language:

english

File:

PDF, 135 KB

english, 2002

35

Competitiveness in follow-on drug R&D: a race or imitation?

DiMasi, Joseph A., Faden, Laura B.

Journal:

Nature Reviews Drug Discovery

Year:

2010

Language:

english

File:

PDF, 256 KB

english, 2010

36

The economics of follow-on drug research and development

Joseph A. DiMasi Ph.D.,Cherie Paquette

Journal:

PharmacoEconomics

Year:

2004

Language:

english

File:

PDF, 249 KB

english, 2004

37

A NEW LOOK AT UNITED STATES DRUG DEVELOPMENT AND APPROVAL TIMES

DiMasi, Joseph A.

Journal:

American Journal of Therapeutics

Year:

1996

File:

PDF, 924 KB

1996

38

Resonant x-ray reflectivity from a bromine-labeled fatty acid Langmuir monolayer

Strzalka, Joseph, DiMasi, Elaine, Kuzmenko, Ivan, Gog, Thomas, Blasie, J. Kent

Journal:

Physical Review E

Year:

2004

Language:

english

File:

PDF, 137 KB

english, 2004

39

Platelet Activation via Shear Stress Exposure Induces a Differing Pattern of Biomarkers of Activation versus Biochemical Agonists

Roka-Moiia, Yana, Walk, Ryan, Palomares, Daniel E., Ammann, Kaitlyn R., Dimasi, Annalisa, Italiano, Joseph E., Sheriff, Jawaad, Bluestein, Danny, Slepian, Marvin J.

Journal:

Thrombosis and Haemostasis

Year:

2020

File:

PDF, 717 KB

2020

40

Mandatory Comparator Trials for Therapeutically Similar Drugs: An Assessment of the Facts

Milne, Christopher-Paul, Kaitin, Kenneth I, DiMasi, Joseph A

Journal:

American Journal of Therapeutics

Year:

2007

Language:

english

File:

PDF, 52 KB

english, 2007

41

Cost Drivers of a Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Phase 3 Clinical Trial

Stergiopoulos, Stella, Calvert, Sara B, Brown, Carrie A, Awatin, Josephine, Tenaerts, Pamela, Holland, Thomas L, DiMasi, Joseph A, Getz, Kenneth A

Journal:

Clinical Infectious Diseases

Year:

2018

Language:

english

File:

PDF, 635 KB

english, 2018

42

Commentary

Joseph A. DiMasi

Journal:

Managerial and Decision Economics

Year:

2007

Language:

english

File:

PDF, 120 KB

english, 2007

43

SAE Technical Paper Series [SAE International SAE 2000 World Congress - (MAR. 06, 2000)] SAE Technical Paper Series - Development of a Finite Element Model of the Thor Crash Test Dummy

Canha, Joseph, Dimasi, Frank, Tang, Yim, Haffner, Mark, Shams, Tariq

Year:

2000

Language:

english

File:

PDF, 1.68 MB

english, 2000

44

Solvothermal Synthesis, Development, and Performance of LiFePO 4 Nanostructures

Zhu, Jianxin, Fiore, Joseph, Li, Dongsheng, Kinsinger, Nichola M., Wang, Qianqian, DiMasi, Elaine, Guo, Juchen, Kisailus, David

Journal:

Crystal Growth & Design

Year:

2013

Language:

english

File:

PDF, 2.34 MB

english, 2013

45

Development Times and Approval Success Rates for Drugs to Treat Infectious Diseases

DiMasi, Joseph A., Florez, Maria I., Stergiopoulos, Stella, Peña, Yaritza, Smith, Zachary, Wilkinson, Michael, Getz, Kenneth A.

Journal:

Clinical Pharmacology & Therapeutics

Year:

2019

File:

PDF, 364 KB

2019

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски